Mississippi's attorney general asks the Supreme Court to overturn Roe v Wade; the Biden administration releases more COVID-19 funds to combat the delta variant; Missouri Supreme Court rules to expand health care access.
Mississippi’s attorney general is urging the Supreme Court to overturn Roe v. Wade, the ruling that secured a woman’s right to an abortion, The New York Times reports. Calling the decision “egregiously wrong,” Attorney General Lynn Fitch hopes to sustain a state law that bans most abortions after 15 weeks of pregnancy. The conservative-majority Supreme Court is scheduled to hear arguments on the case in the fall, while lower courts have previously blocked the Mississippi statute. Fitch has argued the scope of abortion rights should be determined through the political process.
Following increasing rates of COVID-19 infections, hospitalizations, and deaths seen across the United States, the White House announced new funds for COVID-19 testing and vaccination will be released, according to The Hill. In particular, about $100 million in new funds will be directed at rural health clinics to aid in vaccine outreach, as these are often located in areas with low vaccination rates and may be more trusted among community members. An additional $1.6 billion will go toward testing in prisons and homeless and domestic violence shelters. The money will come out of the American Rescue Plan relief package.
The Missouri Supreme Court ruled an additional 270,000 low-income individuals will now be eligible for publicly funded health care, NPR reports. Although voters in the state had previously approved a constitutional amendment to adopt Medicaid expansion, the Republican-led legislature declined to implement it. Following this refusal, Governor Mike Parson (R) stopped the plans to bolster the state's health care system. But in an unanimous opinion, the state’s Supreme Court ruled new Medicaid recipients would join the existing pool of beneficiaries in the state.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More